Management 306 Final Memo Write a business memo responding to one of the followi

Question

Management 306 Final Memo Write a business memo responding to one of the following prompts: RU-32 You're the CEO of a global pharmaceutical company. After decades of work (and the investment of hundreds of millions of dollars), your scientists have come up with a major breakthrough. Your new drug, RU-32, is a low-cost anti-diabetic medication that dramatically stabilizes insulin levels. If approved, your company will own the patent on a drug worth billions of dollars. However, during Phase Ill clinical trials, unexpected complications arose, and approval by the FDA is now unlikely. Without FDA approval, you cannot sell RU-32 in the U.S. and most developed countries. However, other countries-primarily developing countries-will allow you to market the drug without U.S FDA approval, You must choose whether to stop all development and cancel the program, or proceed with manufacturing for sale to citizens of developing countries Inform the Board of Directors of your decision. Write a memo explaining your position and your reasons. Be specific and use detailed examples to support your main points Press-Enterprise A statistic taken from the Press-Enterprise states that the average American worker spends about 1.8 hours of every eight hour work day on non-work activities (eg. personal phone calls, internet surfing, etc.) Estimates suggest this lack of productivity costs American business hundreds of millions of dollars annually, but workers say focusing eight hours a day strictly on work-related business is unreasonable and impossible considering we work more hours than ever before. Additionally, workers argue they need to schedule appointments and daily activities when businesses are open. In your opinion, which side makes a stronger case? Write a persuasive memo to your business arguing one side. Be specific and use detailed examples to support your main points 80 F3 F4 FS F7 F8 F9

Explanation / Answer

RU-32

Being the CEO of a Global Pharmaceutica Company, its my duty to address each small and Big issues faced by the company. This time, the issue is concerned with the operations which has involve thousand of Dollars of the company as well as several years time. RU-32 a low cost anti diabetic drug that controls insulin level is produced by the company but unfortunately in the final clinical stage because of unexected compications, FDA approval is in danger. Without FDA approval we cannot sell it in doestic US market neither we can sell it any developed country. However, we have the only option to consider is selling it in developing countries market where FDA approval is not required. To stop the program at this point will result in high loss to the company, thus we can proceed with manufacturing in developing countries is a better option which I suggest. If found suitable with all the board members, we can go forward with setting up of manufacturing units in selected deveoping countries markets where we such medicines are in lacking or are imported for huge costs. It will generate good business as we can still provide the medicine with cheaper cost than imported ones. Although, this type of medicine is first invented by us.Therefore no much question of competition will come. Leaving now, for Board of Directors for further discussion.

Related Questions

Navigate

• Browse (All)
• Browse M
• Subjects

---

---

Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.